JAN FIGART: Open Payments
NPI 1629535174 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 8 payments from 7 companies in 2025. Trend: 2023 $142 · 2024 $240 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Seqirus USA Inc | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Alkermes, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: JARDIANCE, Fluad, Wegovy, VIVITROL, Qelbree, MAVYRET, Cologuard Collection Kit.
Industry payments across OK — which companies pay providers there.
